The Society for Integrative Oncology (SIO) is accepting nominations from SIO members to fill anticipated vacancies on its Board of Trustees. SIO welcomes the nomination of individuals who are researchers, clinicians, clinical researchers, patients and patient advocates. The submission deadline is July 1. Learn more below about eligibility and submission procedures.

 

Eligibility: To be eligible, candidates must meet the following criteria:

• Current SIO Member (or will join)

• Interested in and committed to advancing and maintaining the integrity of integrative oncology

• Willing to contribute at least 5-10 hours per month toward SIO activities

• Willing to participate in SIO advancement, including fund raising

• Willing to participate in the annual SIO conference (2019 conference October 19-21 in New York City.)

• Willing to participate in teleconference call meetings every other month and attend and participate in one annual Board retreat and meeting at the SIO Conference. (The 2019 daylong retreat to be held October 18 from 8 a.m.- 4 p.m. in New York City.)

• Willing to co-chair an SIO Committee, Task Force and/or Special Interest Group

Nomination Materials: Individuals may nominate themselves or others for consideration by sending the nomination along with the nominee’s curriculum vitae and/or resume, as well as a brief introductory paragraph or two stating the nominee’s qualifications, availability and vision for serving on the SIO Board. The identity of the nominator must be included with the nomination materials. If nominating someone other than yourself, acceptance of the nomination must be confirmed in writing via email from the nominee within one week of submission of the nomination. An acceptance confirmation should be sent to info@integrativeonc.org 

Submission of Nominations: All nomination documents must be submitted in WORD or PDF format and sent by email to SIO at info@integrativeonc.org. The deadline for nomination submission is July 1. 

Selection of Trustees: Nominations will be reviewed by the SIO Executive Committee and Board of Trustees, with a slate of nominees presented for vote by the SIO membership.

Trustee Terms: Each Trustee will serve a term of three years. Each trustee will be introduced to the SIO membership at the annual general meeting during the SIO Conference in October 2019 and will begin service at that time.   

Visit us at https://integrativeonc.org  

New Investigator Forum 2019

Society for Integrative Oncology

New Investigator Forum on Integrative Oncology Research Methods

Application deadline: May 28, 2019

Overview:  The Society for Integrative Oncology (SIO) is committed to developing talented young investigators in integrative oncology with its New Investigator Forum on Integrative Oncology Research Methods. We are now accepting New Investigator Forum applications for the 16th International Conference that will be held in New York, NY, October 19-21. Open to advanced doctoral students, postdoctoral trainees and junior faculty, a selected group of scholars will be chosen to meet with internationally recognized leaders in the field and present their research for discussion and constructive feedback. The research may be in its planning stages or work in progress that is not yet completed.

Purpose: Provide students, trainees and junior faculty with an opportunity to have planned research or research in progress reviewed, discussed and critiqued in a supportive environment by experienced and highly regarded integrative oncology experts who have varied clinical and scientific expertise.

The Society for Integrative Oncology elected three new board members and re-elected three board members at the Annual Meeting held in conjunction with SIO’s 15th annual international conference in Scottsdale, Arizona. They took office at the conclusion of the conference.

The Board is pleased to welcome the following three individuals who were newly elected to three-year terms:

We are pleased to once again offer this widely attended Webinar, which originally aired in September. Eugene Ahn, MD will be on hand to provide a live introduction and audience Q&A following Dr. Abrams' pre-recorded presentation.

As cannabis becomes more widely available for medical purposes increasing numbers of cancer patients are reporting benefit from its use. The published medical literature is thin on evidence. Oncologists report that they often recommend medical cannabis for their patients but describe a lack of knowledge to support their recommendations. An internet lore suggests that cannabis may be useful not only for treating symptoms related to cancer and its treatment but to treating cancer itself. Join us to learn the latest information on integrating cannabis into conventional cancer care.